56656 Courses delivered Online

This course is about proactively working together with others in ways that will help you to communicate more efficiently as you engage with each other to bring value to your company and your customers. In addition, the skills, processes and tools taught in this course can bring value to other aspects of your life.

Tea 'N Chat discussing the new A-LEVEL ESA (Externally Lead Assessment) themes with fellow teachers

Give your song ideas a kick with this short, sharp session with acclaimed folk singer and songwriter Josh Bowker.

You'll learn about the legal duties of personal licence holders, and how to deal with Licensing Authorities, along with information relating to objections, fees and hearings.

This course sets out the procedures that sponsors need to follow to gain authorisation to conduct clinical trials under the Regulation, and it summarises and links to the extensive guidance available from the European Commission and the European Medicines Agency. Its companion course CT12 sets out the procedures that sponsors need to follow to conduct authorised clinical trials in compliance with the Regulation. The two courses therefore provide an ideal foundation for understanding and complying with the new law.

In this course we explain how to advertise and promote prescription drugs in various media, whether to healthcare professionals or consumers, in compliance with legal requirements and guidance from the FDA.

This course explains the regulatory requirements for the reporting of adverse events and suspected adverse reactions in clinical trials. It describes how investigators should report to sponsors, and how sponsors should report to regulatory authorities and other stakeholders in the safety of investigational products. It explains how events are characterized as serious or non-serious, expected or unexpected, and it distinguishes the requirements for each category. It describes controlled vocabularies used for coding of events in reports.

The heaviest legal penalties imposed on drug companies concern interactions with healthcare professionals in the context of prescription drug marketing, notably for violations of the Anti-Kickback Statute and the False Claims Act. Monetary penalties have amounted to billions of dollars in some cases.

This course sets out the legal and regulatory requirements for safety reporting in clinical trials of medicinal products under the jurisdictions of the European Union and the USA. It builds on the foundation laid by our companion course CT13, Safety Reporting in Clinical Trials, and provides greater detail of specific requirements in those jurisdictions.

The theory assessment provides delegates with the essential knowledge to select, monitor, manage and plan the correct use of Harnesses and lanyards for use in a MEWP. Delegates successfully completing the e-learning will: Have an awareness of how to correctly identify and select the appropriate form of personal protection against falls from MEWPs. Have a theoretical awareness only of how to check, use, maintain and store a harness and lanyard with manufacturer’s instructions. Have a theoretical awareness of how harnesses and lanyards should be fitted and adjusted.